Debt to Equity Ratio Chart

View Debt to Equity Ratio for ALP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2025 0.00
June 30, 2025
March 31, 2025
December 31, 2024
September 30, 2024 0.02
June 30, 2024 0.0147
March 31, 2024 0.0117
December 31, 2023 0.0086
September 30, 2023 0.0042
June 30, 2023 0.004
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.0012
March 31, 2021 0.0015
December 31, 2020 0.0029
September 30, 2020 0.0029
June 30, 2020 0.0362
March 31, 2020 0.0379
December 31, 2019 0.0366
September 30, 2019 0.0363
Date Value
June 30, 2019 0.0373
March 31, 2019 0.0367
December 31, 2018 0.0214
September 30, 2018 0.0206
June 30, 2018 0.025
March 31, 2018 0.0242
December 31, 2017 0.0014
September 30, 2017 0.001
June 30, 2017 0.0014
March 31, 2017 0.003
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agenus, Inc. -1.458
Amgen, Inc. 4.903
Anika Therapeutics, Inc. 0.1839
BioCryst Pharmaceuticals, Inc. -1.842
Compugen Ltd. 0.0341